About
Stoke Therapeutics Inc (NASDAQ:STOK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 14 2026
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Apr 8 2026
Stoke Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Apr 7 2026
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors
Mar 4 2026
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Feb 24 2026
Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Financials
Revenue
$184.42 M
Market Cap
$1.94 B
EPS
-0.12
Translate